Impact of age partitioning on classification discordance in pediatric ferritin reference intervals

Dien Minh Tran1, Dung Kim Le1, Thao Thu Ngoc1

  • 1Vietnam National Children's Hospital, Hanoi, Vietnam.

Insights

Different ways of dividing pediatric age groups significantly impact ferritin reference interval classifications, especially in infants. Age-resolved analysis is crucial for accurate pediatric reference intervals.

Area of Science:

  • Clinical Chemistry
  • Pediatric Endocrinology
  • Biostatistics

Background:

  • Pediatric reference intervals (RIs) for serum ferritin are essential for diagnosing iron status.
  • Existing age-partitioning strategies for pediatric RIs may not adequately capture physiological changes.
  • The impact of different age-partitioning schemes on ferritin RI classification requires thorough investigation.

Purpose of the Study:

  • To evaluate how various age-partitioning strategies influence the classification of results using discrete pediatric ferritin reference intervals.
  • To compare the performance of data-driven, physiology-informed, and pragmatic age-partitioning schemes.

Main Methods:

  • A prospective cohort of 3,322 healthy children (birth to <19 years) was studied.
  • Serum ferritin was measured, and nonparametric RIs were derived for five distinct age-partitioning schemes.
  • Classification performance was assessed using flagging rates, age-resolved analyses, and discordance metrics relative to a reference scheme.

Main Results:

  • Overall flagging rates were similar across schemes (5.06-5.80%).
  • Substantial age-specific differences in classification were observed, particularly in early infancy and during adolescent transitions.
  • Broader age partitions showed increased discordance (up to 4.64%) and obscured physiological variations, with boundary discordance reaching 15.0% at 6 months.

Conclusions:

  • Despite similar overall flagging rates, age-partitioning strategies significantly affect pediatric ferritin RI classification, especially in early infancy.
  • Broader partitions can obscure physiological variations and increase classification discordance.
  • Age-resolved evaluation is critical for defining accurate pediatric RIs, complementing statistical criteria.
Abstract

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...